Home » Authors » Nuala Moran

Articles by Nuala Moran

SkyePharma Exchanges Share Of Phase III Risk, Reward For $30M

Jan. 17, 2001

Avidex Completes £10M Funding For Programs In T-Cell Receptors

Jan. 17, 2001

Cambridge Drug Eyes Licensing Deals Following £7.5M Financing

Jan. 17, 2001

Phytopharm Sees Encouraging Results In Phase I P54 Study

Jan. 10, 2001

Oxford BioMedica Moving To LSE Following TroVax Trial Approval

Jan. 10, 2001

PhotoCure Reports Skin Cancer Cures In Phase III PDT Trial

Jan. 10, 2001

PhotoCure Reports Skin Cancer Cures In Phase III PDT Trial

Jan. 10, 2001

Oxford BioMedica Moving To LSE Following TroVax Trial Approval

Jan. 10, 2001

Phytopharm Sees Encouraging Results In Phase I P54 Study

Jan. 10, 2001

Oxxon Plans Moves Into Phase II Following £4.7M Private Funding

Jan. 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 3, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
First atlas of the endometrium with polycystic ovary syndrome
BioWorld Science
Although the causes of polycystic ovary syndrome (PCOS) are unclear, researchers know this condition leads to endometrial dysfunction in women who have hormonal...
Impact of Trump tariffs on med tech proving difficult to anticipate
BioWorld MedTech
The Trump administration’s declaration of a new round of tariffs did not sit well with trade associations, but the impact of those tariffs may vary somewhat by...